DLD and diabetes mellitus: Transcriptional changes in cardiomyocytes of DM patients have been analyzed using the myocyte-specific GEM, iMyocyte2419, revealing deregulation of metabolic pathways ultimately linked to dihydro-lipoamide dehydrogenase, a unique characteristic of myocyte response in DM (101).